1. Summary Information
|
|
|
Country |
India |
|
Company Name |
HLL LIFECARE
LIMITED |
Principal Name 1 |
Mr. Ayyappan Madhavan Nair |
|
Status |
Good |
Principal Name 2 |
Mr. Suresh Kumar Krishna Panicker Kalampu Kattu |
|
|
|
Registration # |
09-002621 |
|
Street Address |
HLL
Bhavan, Mahilamandiram Road, Pooja Ppura, Thiruvananthapuram, Kerala-695012,
India |
||
|
Established Date |
01.03.1966 |
SIC Code |
-- |
|
Telephone# |
91- 471-2355713 |
Business Style 1 |
Manufacturer |
|
Fax # |
91- 471-2358890 |
Business Style 2 |
Marketer |
|
Homepage |
Product Name 1 |
Contraceptive Products |
|
|
# of employees |
Not Available |
Product Name 2 |
Hospital Products |
|
Paid up capital |
Rs.155,350,000 /- |
Product Name 3 |
Pharma Products |
|
Shareholders |
Government [Central and State]
- 100.00 % |
Banking |
State
Bank of India |
|
Public Limited Corp. |
No |
Business Period |
47 Years |
|
IPO |
No |
International Ins. |
- |
|
Public |
No |
Rating |
A
(60) |
|
Related
Company |
|||
|
Relation
|
Country
|
Company
Name |
CEO |
|
Joint
venture |
India |
Life Spring Hospitals Private Limited |
-- |
|
Note |
- |
||
2. Summary
Financial Statement
|
Balance Sheet as of |
31.03.2012 |
(Unit: Indian Rs.) |
|
|
Assets |
Liabilities |
||
|
Current Assets |
7,592,952,000 |
Current Liabilities |
2,110,574,000 |
|
Inventories |
743,483,000 |
Long-term Liabilities |
1,511,740,000
|
|
Fixed Assets |
1,319,021,000 |
Other Liabilities |
4,391,316,000 |
|
Deferred Assets |
0,000 |
Total Liabilities |
8,013,630,000 |
|
Invest& other Assets |
3,84,783,000 |
Retained Earnings |
1,591,259,000 |
|
|
|
Net Worth |
2,026,609,000 |
|
Total Assets |
10,040,239,000 |
Total Liab. & Equity |
10,040,239,000 |
|
Total Assets (Previous Year) |
8,352,055,000 |
|
|
|
P/L Statement as of |
31.03.2012 |
(Unit: Indian Rs.) |
|
|
Sales |
6085,572,000 |
Net Profit |
205,405,000 |
|
Sales(Previous yr) |
5331,062,000 |
Net Profit(Prev.yr) |
183,138,000 |
MIRA
INFORM REPORT
|
Report Date : |
04.03.2013 |
IDENTIFICATION DETAILS
|
Name : |
HLL LIFECARE LIMITED (w.e.f. 01.01.2009) |
|
|
|
|
Formerly Known
as : |
HINDUSTAN LATEX LIMITED |
|
|
|
|
Registered
Office : |
HLL Bhavan, Mahilamandiram Road, Pooja Ppura, Thiruvananthapuram, Kerala-695012 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2012 |
|
|
|
|
Date of
Incorporation : |
01.03.1966 |
|
|
|
|
Com. Reg. No.: |
09-002621 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs. 155.350 millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U25193KL1966GOI002621 |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAACH5598K |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company |
|
|
|
|
Line of Business
: |
Subject is a leading manufacturer and marketer of a range of contraceptive products around the globe. Subject also provides a variety of hospital products, pharma products and healthcare delivery services. |
|
|
|
|
No. of Employees
: |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
A (60) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
Maximum Credit Limit : |
USD 8100000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a 100% government of India owned entity. It is a well established company having a good track record.
Financially company appears to be strong. Performance capability seems to be
high. The subject gets good financial support from government. Trade relations are reported to be fair. Business is active. Payments
are reported to be regular and as per commitment. The company can be considered for normal business dealings at usual
trade terms and condition. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2012
|
Country Name |
Previous Rating (31.03.2012) |
Current Rating (30.06.2012) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INDIAN ECONOMIC OVERVIEW
India is developing into an open-market economy, yet traces
of its past autarkic policies remain. Economic liberalization, including industrial
deregulation, privatization of state-owned enterprises, and reduced controls on
foreign trade and investment, began in the early 1990s and has served to
accelerate the country's growth, which has averaged more than 7% per year since
1997. India's diverse economy encompasses traditional village farming, modern
agriculture, handicrafts, a wide range of modern industries, and a multitude of
services. Slightly more than half of the work force is in agriculture, but
services are the major source of economic growth, accounting for more than half
of India's output, with only one-third of its labor force. India has
capitalized on its large educated English-speaking population to become a major
exporter of information technology services and software workers. In 2010, the
Indian economy rebounded robustly from the global financial crisis - in large
part because of strong domestic demand - and growth exceeded 8% year-on-year in
real terms. However, India's economic growth in 2011 slowed because of persistently
high inflation and interest rates and little progress on economic reforms. High
international crude prices have exacerbated the government's fuel subsidy
expenditures contributing to a higher fiscal deficit, and a worsening current
account deficit. Little economic reform took place in 2011 largely due to
corruption scandals that have slowed legislative work. India's medium-term
growth outlook is positive due to a young population and corresponding low
dependency ratio, healthy savings and investment rates, and increasing
integration into the global economy. India has many long-term challenges that
it has not yet fully addressed, including widespread poverty, inadequate
physical and social infrastructure, limited non-agricultural employment
opportunities, scarce access to quality basic and higher education, and
accommodating rural-to-urban migration.
|
Source
: CIA |
EXTERNAL AGENCY RATING
|
Rating Agency Name |
ICRA |
|
Rating |
A (Long term rating) |
|
Rating Explanation |
Having adequate degree of safety regarding timely servicing of
financial obligation it carry low credit risk. |
|
Date |
July, 2011 |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter in
the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2012.
LOCATIONS
|
Registered Office : |
HLL Bhavan, Mahilamandiram Road, Pooja Ppura,
Thiruvananthapuram, Kerala-695012, India |
|
Tel. No.: |
91- 471-2355713 |
|
Fax No.: |
91- 471-2358890 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Corporate Head Office : |
Mahilamandiram Road, Poojappura, Thiruvananthapuram –
695012, Kerala, India |
|
Tel. No.: |
91-471 2354949 |
|
Fax No.: |
91-471 2354949 |
|
E-Mail : |
|
|
|
|
|
Factory 1 : |
Peroorkada, Thiruvananthapuram-695005, Kerala, India |
|
Tel. No.: |
91-471-2437270 / 2433602 |
|
Fax No.: |
91-471-2432409 / 2435013 |
|
E-Mail : |
|
|
|
|
|
Factory 2 : |
Kanagala , Belgaum - 591225Karnataka , India |
|
Tel. No.: |
91-91-8333-279244 / 279207 |
|
Fax No.: |
91-91-8333-279245 / 279206 |
|
E-Mail : |
|
|
|
|
|
Factory 3 : |
Plot No.16-A/1, Cochin Special Economic Zone
Kakkanad, Cochin-682037 Kerala, India |
|
Tel. No.: |
91-484-2413332 / 241 |
|
Fax No.: |
91-484-2413293 |
|
E-Mail : |
|
|
|
|
|
Factory 4 : |
Pidched road, survey No. 1005 A ,Medak, Gajewal - 502278, Andhrapradesh, India |
|
E-Mail : |
|
|
|
|
|
Factory 5 : |
Akkulam, Thiruvananthapuram Kerala, India |
|
Tel. No.: |
91-471-2441384 / 2442641 |
|
Fax No.: |
91-471-2441383 |
|
E-Mail : |
|
|
|
|
|
Factory 6 : |
Plot No. 71, Sector 7, IMT, Manesar, Gurgaon–122051 Haryana, India |
|
Tel. No.: |
91-124-4030949 |
|
Fax No.: |
91-124-4030949 |
|
E-Mail : |
|
|
|
|
|
Factory 6 : |
11/12C,Sector E, Sanwer Road,Industrial Area,
Indore-452015, Madhaya Pradesh, India |
|
Tel. No.: |
91-731-2723016 / 2723017 |
|
Fax No.: |
91-731-2723016 / 2723017 |
|
E-Mail : |
DIRECTORS
As on 24.09.2012
|
Name : |
Mr. Ayyappan Madhavan Nair |
|
Designation : |
Managing director |
|
Address : |
Sreeprasadam, Thamarakulam Lane, Sasthamangalam,
Thiruvananthapuram-695010, Kerala, India |
|
Date of Birth/Age : |
22.05.1956 |
|
Qualification : |
Btech, MBA |
|
Date of Appointment : |
01.08.2008 |
|
PAN No.: |
ABGPN2668C |
|
Voter ID No.: |
FVM1101617 |
|
DIN No.: |
00117374 |
|
|
|
|
Name : |
Mr. Suresh Kumar Krishna Panicker Kalampu Kattu |
|
Designation : |
Whole-time director |
|
Address : |
Pranaman, T.C. VI/1284/8, Pipeline Road, Thiruvananthapuram-695030, Kerala, India |
|
Date of Birth/Age : |
29.11.1956 |
|
Qualification : |
B. tech |
|
Date of Appointment : |
19.02.2009 |
|
PAN No.: |
AEUPP8564N |
|
Voter ID No.: |
HVX2308302 |
|
DIN No.: |
00061232 |
|
|
|
|
Name : |
Mr. Rakesh Prasad Khandelwal |
|
Designation : |
Whole-time director |
|
Address : |
E-504, Isptika Appartment, Plot No.27, Sector 4, Dwaraka, New Delhi,
India |
|
Date of Birth/Age : |
03.05.1958 |
|
Qualification : |
MBA,AICWA,A CS,LLB |
|
Date of Appointment : |
12.05.2009 |
|
PAN No.: |
AEFPK4315K |
|
DIN No.: |
00388355 |
|
|
|
|
Name : |
Mr. Sanjiv Kapoor |
|
Designation : |
Director |
|
Address : |
13/397, Civil Lines, Kanpur, Uttar Pradesh, India |
|
Date of Birth/Age : |
04.10.1953 |
|
Date of Appointment : |
03.12.2010 |
|
DIN No.: |
00004005 |
|
|
|
|
Name : |
Ms. Aarti Vij |
|
Designation : |
Director |
|
Address : |
House No.31, Friends Coloney, New Delhi-110065, India |
|
Date of Birth/Age : |
16.11.1963 |
|
Date of Appointment : |
03.12.2010 |
|
DIN No.: |
03413556 |
|
|
|
|
Name : |
Mr. Simhambhatla Kameswara Rao |
|
Designation : |
Nominee director |
|
Address : |
D-11/83, Pandara Road, New Delhi-110001, India |
|
Date of Birth/Age : |
10.07.1956 |
|
Date of Appointment : |
12.09.2012 |
|
DIN No.: |
06426779 |
|
|
|
|
Name : |
Mr. Rajiv Ramchandra Takru |
|
Designation : |
Nominee director |
|
Address : |
D-11/129, Kaka Nagar, New Delhi-110003, India |
|
Date of Birth/Age : |
26.09.1955 |
|
Date of Appointment : |
12.09.2012 |
|
DIN No.: |
02023255 |
|
|
|
|
Name : |
Mr. Mohandas Karunakaran Nair |
|
Designation : |
Director |
|
Address : |
TC-4/1804, Ushasandhya, T.T.C. Junction, Kowdiar, Trivandrum-695003,
Kerala, India |
|
Date of Birth/Age : |
18.02.1952 |
|
Date of Appointment : |
07.01.2013 |
|
DIN No.: |
06493283 |
|
|
|
|
Name : |
Mr. Santhana Krishnan |
|
Designation : |
Whole time Director |
|
Address : |
TC 12/759 (19), Flat No. 4-B, Cloud 9, Apartments, Law College Road, Kunnukuzhi,
Thiruvananthapuram-695035, Kerala, India |
|
Date of Birth/Age : |
13.05.1956 |
|
Date of Appointment : |
12.02.2013 |
|
DIN No.: |
06507938 |
KEY EXECUTIVES
|
Name : |
Mr. P Sreekumar |
|
Designation : |
Secretary |
|
Address : |
Jasmine, E12 Sastri Nagar, Karamana PO, Thiruvananthapuram-695002,
Kerala, India |
|
Date of Birth/Age : |
30.05.1959 |
|
Date of Appointment : |
31.05.2012 |
|
PAN No.: |
ABFPN3963P |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 24.09.2012
|
Names of Shareholders |
|
No. of Shares |
|
The President of India |
|
155344 |
|
P.K. Pradhan |
|
1 |
|
Rajiv Takru |
|
1 |
|
S. K. Rao |
|
1 |
|
M. Ayyappan |
|
1 |
|
K.K. Sureshkumar |
|
1 |
|
R.P. Khandelwal |
|
1 |
|
Total |
|
155350 |
Allottees as on 04.12.2012
|
Names of Allottees |
|
No. of Shares |
|
The president of India |
|
1500000 |
|
The president of India |
|
280000 |
|
Total |
|
1780000 |
Equity Share Break up (Percentage of Total Equity)
As on 24.09.2012
|
Category |
Percentage |
|
Government [Central and State] |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Subject is a leading manufacturer and marketer of a range
of contraceptive products around the globe. Subject also provides a variety
of hospital products, pharma products and healthcare delivery services. |
||||||||
|
|
|
||||||||
|
Products : |
|
GENERAL INFORMATION
|
No. of Employees : |
Not Available |
||||||||||||
|
|
|
||||||||||||
|
Bankers : |
State Bank of India, Commercial Branch, Thycaud, Thiruvananthapuram-695014, Kerala, India |
||||||||||||
|
|
|
||||||||||||
|
Facilities : |
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Ananthan and Sundaram Chartered Accountants |
|
Address : |
Sivakarthi, 123, Sankar Nagar, Neeramankara, Kaimanam P.O , Thiruvananthapuram, Kerala, India |
|
PAN No.: |
AAEFA3563E |
|
|
|
|
Joint venture : |
Life Spring Hospitals Private Limited, India CIN No.: U85110KL2008PTC021819 |
|
|
|
|
Associate : |
Hindustan Latex Family Planning Promotion Trust, India |
CAPITAL STRUCTURE
After 24.09.2012
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
3000000 |
Equity Shares |
Rs.1000/- each |
Rs. 3000.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
1935350 |
Equity Shares |
Rs.1000/- each |
Rs. 1935.350 Millions |
|
|
|
|
|
As on 31.03.2012
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
200000 |
Equity Shares |
Rs.1000/- each |
Rs. 200.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
155350 |
Equity Shares |
Rs.1000/- each |
Rs. 155.350 Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
155.350 |
155.350 |
155.350 |
|
|
2] Share Application Money |
280.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
1591.259 |
1404.250 |
1247.075 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
2026.609 |
1559.600 |
1402.425 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
1511.740 |
1576.146 |
877.172 |
|
|
2] Unsecured Loans |
0.000 |
0.000 |
0.000 |
|
|
TOTAL BORROWING |
1511.740 |
1576.146 |
877.172 |
|
|
DEFERRED TAX LIABILITIES |
35.376 |
35.137 |
32.758 |
|
|
|
|
|
|
|
|
TOTAL |
3573.725 |
3170.883 |
2312.355 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
1319.021 |
1167.458 |
1224.864 |
|
|
Capital work-in-progress |
306.241 |
158.117 |
23.041 |
|
|
|
|
|
|
|
|
INVESTMENT |
78.542 |
78.542 |
78.542 |
|
|
DEFERRED TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
743.483
|
573.931 |
531.200 |
|
|
Sundry Debtors |
2442.182
|
2269.923 |
1177.675 |
|
|
Cash & Bank Balances |
142.370
|
509.295 |
445.723 |
|
|
Other Current Assets |
4363.726
|
3158.284 |
143.728 |
|
|
Loans & Advances |
644.674
|
436.505 |
298.562 |
|
Total
Current Assets |
8336.435
|
6947.938 |
2596.888 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
791.055
|
829.467 |
609.712 |
|
|
Other Current Liabilities |
1319.519
|
1146.300 |
927.308 |
|
|
Provisions |
4355.940
|
3205.405 |
73.960 |
|
Total
Current Liabilities |
6466.514
|
5181.172 |
1610.980 |
|
|
Net Current Assets |
1869.921
|
1766.766 |
985.908 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
3573.725 |
3170.883 |
2312.355 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
6085.572 |
5331.062 |
4400.629 |
|
|
|
Other Income |
103.730 |
80.923 |
204.189 |
|
|
|
TOTAL (A) |
6189.302 |
5411.985 |
4604.818 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Cost of materials consumed |
1395.058 |
1378.357 |
|
|
|
|
Purchases of stock-in-trade |
866.304 |
809.273 |
4175.166 |
|
|
|
Employee benefit expense |
1085.140 |
987.629 |
|
|
|
|
Other expenses |
2395.082 |
1764.640 |
|
|
|
|
Changes in inventories of finished goods, work-in-progress and stock-in-trade |
(93.650) |
0.786 |
|
|
|
|
TOTAL (B) |
5647.934 |
4940.685 |
4175.166 |
|
|
|
|
|
|
|
|
Less |
PROFIT/
(LOSS) BEFORE INTEREST, TAX,
DEPRECIATION AND AMORTISATION (A-B) |
541.368 |
471.300 |
429.652 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
77.583 |
52.437 |
75.605 |
|
|
|
|
|
|
|
|
|
|
PROFIT
/ (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
463.785 |
418.863 |
354.047 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
158.147 |
145.133 |
127.907 |
|
|
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) BEFORE TAX (E-F) (G) |
305.638 |
273.730 |
226.140 |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
100.233 |
90.592 |
76.801 |
|
|
|
|
|
|
|
|
|
|
PROFIT/
(LOSS) AFTER TAX (G-H) (I) |
205.405 |
183.138 |
149.339 |
|
|
|
|
|
|
|
|
|
Less |
APPROPRIATIONS |
|
|
|
|
|
|
|
Transfer to General Reserve |
NA |
NA |
122.076 |
|
|
|
Dividend |
NA |
NA |
3.960 |
|
|
|
Tax on Dividend |
NA |
NA |
23.303 |
|
|
BALANCE CARRIED
TO THE B/S |
NA |
NA |
0.000 |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
|
|
|
|
|
|
|
FOB value of manufactured goods exported |
405.446 |
512.622 |
|
|
|
|
FOB value of traded goods exported |
90.538 |
0.000 |
|
|
|
TOTAL EARNINGS |
495.984 |
512.622 |
518.200 |
|
|
|
|
|
|
|
|
|
|
Earnings /
(Loss) Per Share (Rs.) |
1332.21 |
1186.67 |
96.131 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2012 |
31.03.2011 |
31.03.2010 |
|
PAT / Total Income |
(%) |
3.32
|
3.38 |
3.24 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
53.02
|
5.13 |
5.14 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
3.17
|
3.37 |
5.92 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.15
|
0.18 |
0.16 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Debt/Networth) |
|
0.75
|
1.01 |
0.63 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.29
|
1.34 |
1.61 |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check List by Info Agents |
Available in
Report (Yes / No) |
|
1] |
Year of Establishment |
Yes |
|
2] |
Locality of the firm |
Yes |
|
3] |
Constitutions of the firm |
Yes |
|
4] |
Premises details |
No |
|
5] |
Type of Business |
Yes |
|
6] |
Line of Business |
Yes |
|
7] |
Promoter's background |
Yes |
|
8] |
No. of employees |
No |
|
9] |
Name of person contacted |
No |
|
10] |
Designation of contact
person |
No |
|
11] |
Turnover of firm for last
three years |
Yes |
|
12] |
Profitability for last
three years |
Yes |
|
13] |
Reasons for variation
<> 20% |
----- |
|
14] |
Estimation for coming financial
year |
No |
|
15] |
Capital in the business |
Yes |
|
16] |
Details of sister
concerns |
Yes |
|
17] |
Major suppliers |
No |
|
18] |
Major customers |
No |
|
19] |
Payments terms |
No |
|
20] |
Export / Import details
(if applicable) |
No |
|
21] |
Market information |
----- |
|
22] |
Litigations that the firm
/ promoter involved in |
----- |
|
23] |
Banking Details |
Yes |
|
24] |
Banking facility details |
Yes |
|
25] |
Conduct of the banking
account |
----- |
|
26] |
Buyer visit details |
----- |
|
27] |
Financials, if provided |
Yes |
|
28] |
Incorporation details, if
applicable |
Yes |
|
29] |
Last accounts filed at
ROC |
Yes |
|
30] |
Major Shareholders, if
available |
Yes |
|
31] |
Date of Birth of
Proprietor/Partner/Director, if available |
Yes |
|
32] |
PAN of
Proprietor/Partner/Director, if available |
Yes |
|
33] |
Voter ID No of
Proprietor/Partner/Director, if available |
Yes |
|
34] |
External Agency Rating,
if available |
Yes |
NOTE
The registered office of the company has been shifted from Latex Bhavan
Mahilamandiram Road, Poojappura Trivandrum-695012, Kerala, India to the present
address w.e.f. 21.12.2009
BUSINESS REVIEW
HLL is a leading manufacturer and marketer of a range of contraceptive products around the globe. It also provides a variety of hospital products, pharma products and healthcare delivery services.
FINANCIAL PERFORMANCE
Notwithstanding the slowdown in economy, the company continues to maintain its growth momentum. Company’s performance during the year 2011-12, in terms of operational and financial, has shown a marked improvement over the previous year. Company’s Total Revenue during the year 2011-12 has grown by 14.36% to Rs. 6189.300 Millions against Rs. 5411.900 Millions in the previous year and Net Profit before Tax by 11.16% to Rs. 30.56 Millions against Rs. 27.49 Millions in the previous year. The Net Profit after Tax has grown by 11.45% from Rs. 184.300 Millions in 2010-11 to Rs. 205.400 Millions in 2011-12.
Considering the value of transactions handled by the Procurement and Consultancy Division and Infrastructure Division, the total business handled by the company is Rs. 11120.000 Millions compared to Rs. 11310.000 Millions during the previous year.
DIVERSIFICATION
/EXPANSION
Sanitary napkins manufacturing unit
In furtherance of company’s philosophy to expand its presence in value added products space, it has undertaken a project for production of Sanitary Napkin at Kanagala Factory, Belgaum, with an installed capacity of 200 million pieces per annum, at a cost of Rs. 85.000 Millions The production from the unit is currently used for catering to the needs of Ministry of Health and Family Welfare, Government of India and other State governments. This facility was commissioned in April 2012. In order to meet the increased demand, the company has initiated steps to augment the capacity to 500 million pieces per annum.
Natural Rubber based Female Condoms manufacturing facility at KFC
Corporate R and D Division has been successful in developing Natural Rubber based Female Condoms. The company is setting up a manufacturing facility for Natural Rubber based Female Condoms at an estimated project cost of Rs. 19.600 Millions The Civil construction of the facility coming up at Kakkanad factory, Cochin is nearing completion.
Facility Management Division
A Facility Management Division has been formed for providing facility management services to clients. The division provides both hard and soft services including operation and maintenance, integrated building management, Housekeeping, Security services, Horticulture services, Warehouse Management, Hospitality services, Support services etc.
New Contraceptive Packing and Storage Unit at
Balaramapuram, Thiruvananthapuram
On 6th February,2012, Shri Sudip Bandyopadhyay, Hon’ble Union Minister of State for Health and Family Welfare laid foundation stone for the Company’s new Contraceptives Packing and Storage unit building at Balaramapuram, Thiruvananthapuram with an area of 51000 sq. ft. The new unit is envisaged as an integrated facility for Condom Packing and Storage.
Facility for Safety Testing and Calibration of Medical
Equipments
Testing and calibration of medical equipments is emerging as a matter of internal need for hospitals to get Quality accreditations (ISO, NABL certifications etc.) for brand building. The Company proposes to start a facility for rendering service of Safety Testing and Calibration of Medical Equipment used in Hospitals. The capital outlay for setting up the facility is estimated at Rs. 8.500 millions. Procurement Consultancy Division (PCD) of the company could leverage on the proposed capability of Bio Medical Department. This facility could offer Testing and Calibration of equipments procured through PCD as a value added business proposition to the clients. This would compliment both businesses and would maximize the company’s overall value creation.
Proposal for Capacity Augmentation of Surgical Suture
manufacturing facility
The Company foresees Suture production to touch 126,000 dozens, reaching a turnover of Rs. 85.000 Millions and the present capacity utilization is likely to cross 100% soon. The company plans to increase production capacity to 0.625 million dozens per annum by 2016-17 at an estimated project cost of Rs. 60.000 Millions
New facility for manufacturing Male Condoms
During the year, the Company has taken on lease a production facility from M/s Indus Medicare Limited, Hyderabad for manufacturing Condoms. This facility is situated at Survey No.1005A, AA, Gajwel Village and Mandal, Medak District, Andhra Pradesh-502278 and has annual installed capacity for manufacturing 120 M.Pcs of Condoms.
AWARDS AND ACCOLADES
During the year, the Company and its factories won the following awards and recognitions:
Energy Conservation Award in the Heavy Industries Category in December, 2011.
Peroorkada Factory, Thiruvananthapuram
MKK Nair Productivity Awards in the medium-Large Industries category for the year 2010-2011.
GREENTECH Award 2011 in Gold Star Category for effective excellence in Environment Management System.
Award from Kerala State Factories and Boilers 2011 for outstanding safety performance for very large factories of Rubber and Plastics category.
Awards from National Safety council (Kerala Chapter) 2011 for outstanding safety performance.
Akkulam Factory, Thiruvananthapuram
Secured second price of “Factory Safety Award” for medium scale industries from Kerala State Factories and Boilers department, Government of Kerala.
MANAGEMENT DISCUSSION
AND ANALYSIS
OVERVIEW
Healthcare Industry
The healthcare sector in India is a key sector poised for substantial growth in the coming years. At present, the $65 billion domestic healthcare industry is growing at around 20% a year and according to ratings agency Fitch, the Indian healthcare sector will swell to $100 billion by 2015. There have been a number of crucial initiatives taken up by the Government of India for the enhancement of the healthcare sector in the country. These initiatives center on investments that are closely linked to providing better medical infrastructure, rural health facilities etc.
• 100 per cent foreign direct investment (FDI) is permitted for health and medical services under the automatic route.
• The National Rural Health Mission (NHRM) had allocated $10.15 billion for the up- gradation and capacity enhancement of healthcare facilities.
• In order to meet revised cost of construction, the Government had allocated an additional $1.2 billion for six upcoming AIIMS-like institutes and up-gradation of 13 existing Government Medical Colleges.
In the Union Budget for year 2012-13, budget allocation has been hiked by nearly 14 percent to Rs.304770.000 millions for the Health care Sector, against previous year’s allocation of Rs. 267600.000 millions, with special focus on cheaper lifesaving drugs and better health facilities for the rural and urban poor. The budget for 2012-13 also focused on better health services to the poor in rural as well as urban slums, increasing the outlay of the National Rural Health Mission (NRHM) from Rs. 1811.500 millions in 2011-12 to Rs. 208220.000 millions in 2012-13. To target the urban poor, the government also launched the National Urban Health Mission, which aims to provide basic primary health needs of the people who live in cities. Aiming to reach out to people living in the remotest part of the country, the government has already started upgrading the existing hospitals and establishing new hospitals under the Pradhan Mantri Swasthya Suraksha Yojana (PMSSY).
A kaleidoscopic view of India in the coming years show favourable demographics that will fuel the growth of the healthcare and pharmaceutical sector - rising disposable income levels, increasing population and shift in disease patterns. The healthcare industry will have to seize the opportunities and challenges that this change will stimulate and will have to find innovative ways to address them.
FIXED ASSETS
· Buildings
· Plant and equipment
· Furniture and fixtures
· Vehicles
· Office equipment
WEB DETAILS
HISTORY
Long ago, in 1966, a quiet revolution took place in
Trivandrum, also known as Thiruvananthapuram, a small picturesque town located
in the south-western part of India. The revolution, called HLL, swept through
the length and breadth of the country. It reigned in the alarming population
growth and enhanced the quality of life of families in India. A revolution that
eventually sparked off many a movement and idea, it brought quality healthcare
and prosperity to the doorstep of millions. The revolution resulted in creating
a healthier India, with a record of 189 million couple year protections (CYPs*)
during the past four decades.
We call it the Pink Revolution. The revolution, which today, has reached every corner of the country as well as many parts of the world, addressing public health challenges and bringing good health and happiness in its wake.
HLL’s first plant began operations on April 5, 1969 at Peroorkada in Thiruvananthapuram district of Kerala. The plant was established in technical collaboration with M/s Okamoto Industries Inc. Japan.
Today, seven manufacturing plants later, HLL has grown into a multi-product, multi-unit organisation addressing various public health challenges facing humanity. In 2003, when HLL had a turnover of a mere INR 163 crores, it had set its sights on becoming a INR10,000 crore company by 2020.
By 2010, HLL not only surpassed this figure but also drew a clear road map to achieve five-fold growth by 2020.
The recognitions and laurels soon followed. Now, HLL is a Mini Ratna, upgraded as a Schedule B Central Public Sector Enterprise. The company received the Prime Minister Award for being the best public sector enterprise in India. It is also the only company in the world which manufactures and markets such a wide range of contraceptives. Today, HLL produces 1.316 billion condoms annually, making it one of the world’s leading condom manufacturers, accounting for nearly 10 percent of the global production capacity.
Over the years each of the initiatives taken up by HLL have been aimed at providing quality healthcare to every family. HLL’s ssociate institutions, Hindustan Latex Family Planning Promotion Trust (HLFPPT) and LifeSpring Hospitals, have ensured this to the nation’s underserved and vulnerable populace, at an affordable cost.
With a vast array of innovative products, services and social programmes to meet the country’s healthcare needs, HLL Lifecare Limited is firmly on track, with its motto of 'Innovating for Healthy Generations'.
HLL continues to make its mark by setting new goals and taking on challenges others often view as impossible.
PRESEE RELEASE
HLL WINS INDIRA GANDHI RAJBHASHA AWARD FOR SEVENTH TIME
15 SEP 2012
Thiruvananthapuram: HLL Lifecare Limited has won the prestigious Indira Gandhi Rajbhasha shield for a seventh time for its outstanding performance in implementing the official language, Hindi.
President Pranab Mukherjee presented the award to Dr. M. Ayyappan, Chairman and
Managing Director of HLL, at a function in New Delhi on September 14, on the
occasion of Hindi Diwas.
HLL won the second prize in the C-Region category of the Rajbhasha awards which
have been instituted by the Union Home Ministry and the Department of Official
Language, and are given to public sector units that carry out outstanding work
in promoting and propagating Hindi.
Union Home Minister Sushilkumar Shinde, Minister of State for Home Affairs
Jitendra Singh and senior government officials were present on the occasion.
Hindi Diwas is observed across the country to commemorate the historic occasion
of the adoption of Hindi as the official language of the constituent assembly
on September 14, 1949. The presentation of the Rajbhasha awards by the
President is the high point of the celebrations.
AIIMS OUTSOURCES LAB, PHARMACY OPERATIONS TO HLL LIFECARE.
31 JAN 2013
For the first time, All India Institute of Medical Sciences (AIIMS), Delhi, has outsourced the laboratory and pharmacy operations to an outside organisation –HLL Lifecare Limited.
In the trend-setting move, the AIIMS has entrusted the functioning of
laboratory and pharmacy of its Outreach OPD at Badsha Village of Jhajjar
district in Haryana to HLL Lifecare Limited. Union Minister for Health and
Family Welfare Shri Ghulam Nabi Azad formally inaugurated the OPD on November
24.
Apart from the whole range of laboratory services, HLL will provide generic
medicines in 194 drug categories to all patients through the outreach pharmacy.
HLL Lifecare, the mini-ratna public sector enterprise under the Ministry of
Health through its brands- Hindlabs and Lifecare Centres (LCC)
-provides diagnostic services and retail outlet in pharma and surgical implants
to partner institutions in a Public-Public Partnership (PPP) model. HLL has
been operating specialty diagnostic and pharmacy services in leading health
institutions in Kerala, Orissa and other states in collaboration with the
respective State Health Departments.
“The partnership with AIIMS means that our footprint in this specialty segment
is extended to North India. The collaboration will prove to be a spring-board
for our future expansions in the area. Many other States have also approached
us to avail our services in the division,’’ HLL Chairman and Managing Director
Dr M Ayyappan said.
“Effectiveness of healthcare delivery organizations can be enhanced by focusing
on medical care delivery and outsourcing services like diagnostics, pharmacy
etc to a specialist agency. Outsourcing partnerships offered by HLL through
Hindlabs are made to suit the specific requirement of the partnering
institution,” he said.
Inaugurating the OPD, Shri Azad said due to the high number of patients
visiting AIIMS, most departments were handling workload in excess of their
designed capacity. “As a result of this, patients have to wait for long periods
for various procedures and services. For this reason, the need for expansion of
AIIMS was felt and thus the Outreach OPD at Badsha, Jhajjar has been conceived
and designed to handle approximately 1,000 patients per day”, he said. Haryana
Chief Minister Shri Bhupinder Singh Hooda and Dr Ayyappan were also present on
the occasion.
HLL FORAYS INTO DEO MARKET UNDER THE BRAND NAME MOODS
16 FEB 2013
Thiruvananthapuram, February 14: Next time you walk into a drug store and say “Moods please!” don’t forget to mention a condom or a deodorant.
The hugely popular “Moods”, which has been a scorching success as a masculine
contraceptive device, has now lent its brand image to a new product
range--deodorant for men.
Dabbling in India’s lucrative deodorant segment having a market size pegged at
Rs 9000.000 millions, HLL (HLL Lifecare Limited), a Mini Ratna public sector
global healthcare company and leading provider of quality condoms like Moods,
launched Moods Deo in four variants – TEEZE, FLING, VINK and 4PLAY--here
yesterday.
Moods Deo variants are intended to target young consumers in the 18-30 age
groups, particularly the urban male go-getter. The brand promises “CONFIDENCE
IN A CAN” with a catchy tagline, ‘The Scent Of My Man!’
“We plan to project the product as the catalyst that rejuvenates and
strengthens confidence by helping them overcome all challenges and turning them
desirable,” said Dr. M. Ayyappan, Chairman and Managing Director of the
Thiruvananthapuram-based HLL, while launching the deodorant range.
As for the USP of the product in the deodorant market which has more than 350
brands, Dr. Ayyappan said, “It is round the clock confidence with fragrances
developed by renowned perfumers and inspired by global trends.”
All the four variants have a distinct fragrance. Teeze is mix of Aqua and
Oriental Marine; Fling is based on a mixture of Woody with Citrus; Vink
contains Citrus, Spicy and Floral ingredients; and 4PLAY is a mix of Spicy with
Floral and Fruity notes.
“Moods Deo is refreshing and distinct from other products in the market. Like
the phenomenal success of Moods condom, we are expecting a good demand for
Moods deo as well,” the HLL CMD said. “The tagline for Moods condom is --
Your time, Your place, Your moods. For Moods deodorant, the fragrance is
pleasing round the clock and it surely competes favourably with the best in the
market.”
The four variants, developed by S H Kelkar, Symrise (Germany) and Robertet
(Italy), were chosen through an extensive consumer research in the country.
Men's deodorant forms about 75 per cent of the market with a share of about Rs
6750.000 millions. Deodorant sales grew by 40 per cent in 2010 as
compared to a year earlier. It is projected to grow at 18 per cent CAGR
(compound annual growth rate) over next five years.
HLL, which aggregated a record business of Rs. 11120.000 millions during the fiscal 2011- 2012, has set a sales target of Rs 41.900 millions from Moods deodorant sales during the current financial year.
Starting as a single product company, HLL (formerly Hindustan Latex Limited)
has now transformed into a total contraceptive and holistic healthcare solution
provider. It has emerged as the market leader in contraceptives and ranks
amongst the top manufacturers globally.
The company’s growing portfolio of products and services includes
contraceptives, hospital products, pharmaceuticals, Ayurvedic, personal hygiene
products, diagnostic kits. Its portfolio of services includes Diagnostics
Services Infrastructure Development, Procurement Consultancy and Facility
Management.
HLL LIFECARE TIES UP WITH ENGINEERING COLLEGE FOR RandD PROJECTS
27 FEB 2013
Thiruvananthapuram, Feb 21: Taking a key step forward in its efforts to boost industry-academia linkages, HLL Lifecare, a mini-ratna public sector unit, has teamed up with the Mohandas College of Engineering and Technology (MCET) for collaborative RandD and higher education projects.
HLL Lifecare Chairman and Managing Director Dr M Ayyappan signed a Memorandum
of Understanding with MCET Director Dr. Ashalatha Thampuran for the
establishment of an Institute Industry Interaction Cell which will
provide the facilities and the expertise to improve capabilities for
advanced education and research.
Shri. G. Mohandas, Chairman, MCET, Smt. Rani Mohandas, Director, MCET, and Dr.
K.R.S. Krishnan, Director (Technical and Operations) HLL were present at the
signing of the MoU which envisions knowledge sharing, research interactions,
consultancy and training programmes. HLL will give MCET students the
opportunity to undergo industrial training at its facilities and participate in
active RandD projects.
“We are working towards increasing the relevance of academic research and
consultancy in the research and product development initiatives at HLL,” the
company’s CandMD Dr Ayyappan said. “We are looking at more such partnerships
with leading institutes to help us develop creative solutions and evolve better
products and services for the public, which is our primary objective.”
The tie-up allows for use of MCET’s laboratories and test facilities on a
preferential basis and at concessional rate by HLL, and vice versa. The newly
constituted cell will also facilitate continuing education activities, skill
development and subject upgradation workshops for HLL employees using the
facilities of MCET.
HLL’s experts will support the engineering college in its academic and training
programmes and provide advice in formulating curriculum and syllabus for the
courses offered by the educational institution.
Photo Caption
Dr M Ayyappan, Chairman and Managing Director, HLL Lifecare Limited
and Dr. Ashalatha Thampuran, Director, Mohandas College of Engineering and
Technology (MCET) exchanging a Memorandum of Understanding for
the establishment of an Institute Industry Interaction Cell at HLL
Corporate Head Office, Poojappura. Shri. G. Mohandas, Chairman,
MCET, Smt.Rani Mohandas, Director,MCET, and Dr. K.R.S. Krishnan, Director
(Technical and Operations) HLL are also seen
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No exist to suggest that subject is or was
the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No available
information exist that suggest that subject or any of its principals have been
formally charged or convicted by a competent governmental authority for any
financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.54.48 |
|
|
1 |
Rs.82.72 |
|
Euro |
1 |
Rs.71.27 |
INFORMATION DETAILS
|
Report Prepared
by : |
MRI |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
6 |
|
PAID-UP CAPITAL |
1~10 |
6 |
|
OPERATING SCALE |
1~10 |
7 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
7 |
|
--PROFITABILIRY |
1~10 |
7 |
|
--LIQUIDITY |
1~10 |
7 |
|
--LEVERAGE |
1~10 |
7 |
|
--RESERVES |
1~10 |
7 |
|
--CREDIT LINES |
1~10 |
6 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
DEFAULTER |
|
|
|
--RBI |
YES/NO |
NO |
|
--EPF |
YES/NO |
NO |
|
TOTAL |
|
60 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest capability
for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NB |
NEW BUSINESS |
||
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.